Pharmaceutical client could not obtain desired compound for preclinical work

Three different contractors tried to synthesize over a two-year period


Drug Discovery Alliances selected the appropriate partner to make desired compound for pre-IND needs and Phase-1 clinical trials

The CRO partner is the global leader in process chemistry with a staff comprised of entirely PhD process chemists with decades of pharmaceutical experie


$300 million dollars was realized by client who licensed this asset to a pharmaceutical company

$1 billion dollars in potential down-stream revenues

Deborah Minor